Company
Bioaesthetics
Transforming Lives Through Advancements in Biomaterials
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Legal name
- BioAesthetics Corporation
Claim, correct or request removal
Record updated 28 September 2026
About
BioAesthetics’ Nipple-Areolar Complex Graft, or NACgraft, is a revolutionary next step in breast reconstruction that will provide patients who have had mastectomies with a new, natural, living nipple and areola.
Funding snapshot
- Total raised
- $6.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $5M2021-01
Funding rounds
- Series A
- $5M2021-01, Company stated
- Round, 2020
- $6.4M2020-09-09, SEC form D sold, 75 investors
- Round, 2017
- $500K2017-09-08, SEC form D sold, 1 investor
Products
- Other
- NACgraft
Loading relationship preview